Jeffrey Humphrey's Insider Trades & SAST Disclosures

Jeffrey Humphrey's most recent trade in Lantheus Holdings Inc was a trade of 16,188 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lantheus Holdings Inc
Jeffrey S. Humphrey Chief Medical Officer 17 Jun 2024 16,188 16,188 - - Stock Option (right to buy)
Lantheus Holdings Inc
Jeffrey S. Humphrey Chief Medical Officer 17 Jun 2024 9,076 9,076 (0%) 0% 82.6 749,950 Common Stock
Cyteir Therapeutics Inc
Jeffrey Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 14,150 14,150 - - Stock Option (Right to Buy)
Cyteir Therapeutics Inc
Jeffrey Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 2,358 2,358 - - Stock Option (Right to Buy)
Cyteir Therapeutics Inc
Jeffrey Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2021 28,300 28,300 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades